×

SRMC cancer center once again earns reaccreditation from CoC

SALEM — The University Hospitals Seidman Cancer Center at Salem Regional Medical Center (SRMC) has once again earned reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. This national recognition is awarded to cancer programs that meet rigorous standards for comprehensive, patient-centered care and demonstrate a continuous commitment to improving outcomes for the communities they serve.

To achieve CoC reaccreditation, cancer programs must undergo an extensive evaluation and on-site review every three years.

“Reaccreditation by the Commission on Cancer reflects the exceptional dedication of our physicians, nurses and care teams,” said Anita Hackstedde, M.D., SRMC President/CEO. “It affirms that patients throughout the Mahoning Valley have access to high-quality cancer care close to home, supported by advanced treatment options and the expertise of a nationally recognized cancer program.”

As part of the University Hospitals Seidman Cancer Center network, the program at SRMC provides local access to leading-edge cancer services, including medical oncology, radiation oncology, infusion therapy, clinical trials and supportive care. Patients benefit from a multidisciplinary team approach, where specialists collaborate to develop individualized treatment plans tailored to each patient’s needs.

The Commission on Cancer accreditation program is recognized nationwide as a hallmark of excellence. Accredited programs are committed to providing comprehensive, state-of-the-art cancer care and improving patient outcomes through ongoing quality initiatives.

Fellowship-trained Radiation Oncologist William Demas, M.D., is the Medical Director of the University Hospitals Seidman Cancer Center at Salem Regional Medical Center.

For information about cancer services at the University Hospitals Seidman Cancer Center at Salem Regional Medical Center, visit www.salemregional.com or call 330-332-7672.

Starting at $2.99/week.

Subscribe Today